Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer

Abstract This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and neck cancer.